Diagnosis and Therapy Particularities in Post-Cholecystectomy Cholangitis at Patients with Type 2 Diabetes Mellitus

1. Di Ciaula A, Wang DQ, Portincasa P. Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention. Expert Rev Gastroenterol Hepatol. 2019 Feb;13(2):157-17110.1080/17474124.2019.1549988Search in Google Scholar

2. Di Ciaula A, Molina-Molina E, Bonfrate L, Wang DQ, Dumitrascu DL, Portincasa P. Gastrointestinal defects in gallstone and cholecystectomized patients. Eur J Clin Invest. 2019 Mar; 49(3):e1306610.1111/eci.13066Open DOISearch in Google Scholar

3. Di Ciaula A, Garruti G, Wang DQ, Portincasa P. Cholecystectomy and risk of metabolic syndrome. Eur J Intern Med. 2018 Jul; 53:3-1110.1016/j.ejim.2018.04.019Open DOISearch in Google Scholar

4. Halldestam I, Enell EL, Kullman E, Borch K. Development of symptoms and complications in individuals with asymptomatic gallstones. Br J Surg. 2004 Jun;91(6):734-810.1002/bjs.4547Search in Google Scholar

5. Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016 Jun;37(3):278-31610.1210/er.2015-1137Open DOISearch in Google Scholar

6. van Zon SK, Snieder H, Bültmann U, Reijneveld SA. The interaction of socioeconomic position and type 2 diabetes mellitus family history: a cross-sectional analysis of the Lifelines Cohort and Biobank Study. BMJ Open. 2017 Apr 7;7(4):e015275.10.1136/bmjopen-2016-015275Search in Google Scholar

7. Ali S, Ahamad ST, Talpur AS, Parajuli S, Farooq J. Prevalence of Non-insulin-dependent Diabetes Mellitus Among Patients with Cholelithiasis: A Single-centered, Cross-sectional Study. Cureus. 2018 Apr 7;10(4):e2444.10.7759/cureus.2444Search in Google Scholar

8. Zechner D, Radecke T, Amme J, Bürtin F, Albert AC, Partecke LI, Vollmar B. Impact of diabetes type II and chronic inflammation on pancreatic cancer. BMC Cancer. 2015 Feb 13;15:51.10.1186/s12885-015-1047-xSearch in Google Scholar

9. Hart PA, Bellin MD, Andersen DK, Bradley D, Cruz-Monserrate Z, Forsmark CE, Goodarzi MO, Habtezion A, Korc M, Kudva YC, Pandol SJ. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol. 2016 Nov;1(3):226-23710.1016/S2468-1253(16)30106-6Search in Google Scholar

10. Ramsey ML, Conwell DL, Hart PA. Complications of chronic pancreatitis. Dig Dis Sci. 2017 Jul;62(7):1745-175010.1007/s10620-017-4518-x566754628281169Search in Google Scholar

11. Löhr JM, Dominguez-Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch MM, Haas S, Akisik F, Kartalis N, Iglesias-Garcia J, Keller J. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017 Mar;5(2):153-19910.1177/2050640616684695534936828344786Search in Google Scholar

12. Bellin MD, Whitcomb DC, Abberbock J, Sherman S, Sandhu BS, Gardner TB, Anderson MA, Lewis MD, Alkaade S, Singh VK, Baillie J. Patient and disease characteristics associated with the presence of diabetes mellitus in adults with chronic pancreatitis in the United States. Am J Gastroenterol. 2017 Sep;112(9):1457-146510.1038/ajg.2017.181616829328741615Search in Google Scholar

13. Andersen DK, Korc M, Petersen GM, Eibl G, Li D, Rickels MR, Chari ST, Abbruzzese JL. Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes. 2017 May;66(5):1103-1110.10.2337/db16-1477539960928507210Open DOISearch in Google Scholar

14. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016 Jan-Feb;66(1):7-3010.3322/caac.2133226742998Search in Google Scholar

15. Moses AC, Knudsen LB, Svendsen CB. Comment on Andersen et al, pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas.2014 May;43(4):65710.1097/MPA.0000000000000037420635324713674Open DOISearch in Google Scholar

16. Xiong J, Wang Y, Huang H, Bian J, Wang A, Long J, Zheng Y, Sang X, Xu Y, Lu X, Zhao H. Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma. Oncotarget. 2017 Jul 26;8(35):59648-5965710.18632/oncotarget.19570560176428938668Search in Google Scholar

17. Shafqet M, Sharzehi K. Diabetes and the pancreatobiliary diseases. Curr Treat Options Gastroenterol. 2017 Dec;15(4):508-51910.1007/s11938-017-0163-x29079901Search in Google Scholar

18. Huang YJ, Wu AT, Chiou HY, Chuang MT, Meng TC, Chien LN, Yen Y. Interactive role of diabetes mellitus and female sex in the risk of cholangiocarcinoma: a population-based nested case-control study. Oncotarget. 2017 Jan 24;8(4):6642-665110.18632/oncotarget.14254535165928036262Search in Google Scholar

19. Bragazzi MC, Ridola L, Safarikia S, Di Matteo S, Costantini D, Nevi L, Cardinale V. New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin. Ann Gastroenterol. 2018 Jan-Feb;31(1):42-55Search in Google Scholar

20. Toniolo A, Cassani G, Puggioni A, Rossi A, Colombo A, Onodera T, Ferrannini E. The diabetes pandemic and associated infections: suggestions for clinical microbiology. Rev Med Microbiol. 2019 Jan;30(1):1-1710.1097/MRM.0000000000000155631959030662163Open DOISearch in Google Scholar

21. Koh GC, Peacock SJ, Van der Poll T, Wiersinga WJ. The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):379-8810.1007/s10096-011-1337-4330303721805196Open DOISearch in Google Scholar

22. Cosson E, Catargi B, Cheisson G, Jacqueminet S, Ichai C, Leguerrier AM, Ouattara A, Tauveron I, Bismuth E, Benhamou D, Valensi P. Practical management of diabetes patients before, during and after surgery: A joint French diabetology and anaesthesiology position statement. Diabetes Metab. 2018 Jun;44(3):200-21610.1016/j.diabet.2018.01.01429496345Open DOISearch in Google Scholar

23. Cheisson G, Jacqueminet S, Cosson E, Ichai C, Leguerrier AM, Nicolescu-Catargi B, Ouattara A, Tauveron I, Valensi P, Benhamou D. Perioperative management of adult diabetic patients. Intraoperative period. Anaesth Crit Care Pain Med. 2018 Jun;37 Suppl 1:S21-S25.10.1016/j.accpm.2018.02.01829555547Search in Google Scholar

24. Thompson BM, Stearns JD, Apsey HA, Schlinkert RT, Cook CB. Perioperative management of patients with diabetes and hyperglycemia undergoing elective surgery. Curr Diab Rep. 2016 Jan;16(1):2..10.1007/s11892-015-0700-826699765Search in Google Scholar

25. Thompson BM, Stearns JD, Apsey HA, Schlinkert RT, Cook CB. Perioperative management of patients with diabetes and hyperglycemia undergoing elective surgery. Curr Diab Rep. 2016 Jan;16(1):2.10.1007/s11892-015-0700-8Search in Google Scholar

26. Evans CH, Lee J, Ruhlman MK. Optimal glucose management in the perioperative period. Surg Clin North Am. 2015 Apr;95(2):337-54 Surgical Clinics. 2015 Apr 1;95(2):337-54.10.1016/j.suc.2014.11.00325814110Search in Google Scholar

27. American Diabetes Association. 14. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S144-S151.10.2337/dc18-S01429222385Search in Google Scholar